Pacific Biosciences of California Inc. buy UBS Group AG
Start price
16.02.24
/
50%
€5.53
Target price
16.02.25
€11.13
Performance (%)
-71.92%
Price
17.06.24
€1.55
Summary
This prediction is currently active. Massive losses of -71.92% have been the result for the BUY prediction by UBS_Group_AG. This prediction currently runs until 16.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | -11.408% | -11.408% |
iShares Core DAX® | -2.023% | -3.140% |
iShares Nasdaq 100 | 4.625% | 8.753% |
iShares Nikkei 225® | -2.088% | -0.980% |
iShares S&P 500 | 2.398% | 4.677% |
Comments by UBS_Group_AG for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at UBS Group AG from $12.50 to $12.00. They now have a "buy" rating on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by UBS_Group_AG for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€7.17
17.11.23
17.11.23
€9.20
17.11.24
17.11.24
-78.36%
17.06.24
17.06.24